Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,397,391 papers from all fields of science
Search
Sign In
Create Free Account
Strontium-89
Known as:
Strontium Sr-89
, strontium (89Sr) chloride
, strontium 89
A radioisotope of strontium, a heavy metal found naturally as a non-radioactive element. With a half-life of 50 days, strontium-89 is a beta emitter…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (3)
Metastron
Strontium-89 chloride
strontium chloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
G. Bauman
,
M. Charette
,
R. Reid
,
J. Sathya
Radiotherapy and Oncology
2005
Corpus ID: 4164600
Highly Cited
2003
Highly Cited
2003
Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer…
G. Oosterhof
,
J. Roberts
,
+6 authors
L. Collette
2003
Corpus ID: 71981393
Review
2002
Review
2002
Palliative radiotherapy in the treatment of skeletal metastases
T. Saarto
,
R. Janes
,
M. Tenhunen
,
M. Kouri
European Journal of Pain
2002
Corpus ID: 30976561
Highly Cited
2001
Highly Cited
2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial
S. Tu
,
R. Millikan
,
+9 authors
C. Logothetis
The Lancet
2001
Corpus ID: 2942279
Review
1998
Review
1998
Development, differentiation, and maturation of Kupffer cells
M. Naito
,
G. Hasegawa
,
Kiyoshi Takahashi
Microscopy research and technique (Print)
1998
Corpus ID: 21193303
Primitive macrophages first develop in the murine and human yolk sac and then differentiate into fetal macrophages. Primitive or…
Expand
Highly Cited
1996
Highly Cited
1996
Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.
N. Deb
,
M. Goris
,
+6 authors
S. Knox
Clinical Cancer Research
1996
Corpus ID: 23105335
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory…
Expand
Review
1995
Review
1995
Strontium 89 therapy for the palliation of pain due to osseous metastases.
R. Robinson
,
D. F. Preston
,
Margi Schiefelbein
,
K. G. Baxter
Journal of the American Medical Association (JAMA…
1995
Corpus ID: 30495171
OBJECTIVE To present the current state of systemic radiopharmaceutical therapy for the palliation of pain in individuals with…
Expand
Highly Cited
1989
Highly Cited
1989
Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.
R. Robinson
,
G. Blake
,
+5 authors
D. Ackery
Radiographics
1989
Corpus ID: 262437864
Two hundred and two patients with bone pain from metastatic cancer were treated with 40 microCi/kg of Sr-89. Patients were…
Expand
Highly Cited
1985
Highly Cited
1985
Strontium-89 therapy for the pain of osseous metastases.
E. Silberstein
,
C. Williams
Journal of Nuclear Medicine
1985
Corpus ID: 30843173
A Phase I and II study has been conducted of the safety and efficacy of 89Sr (injected i.v. as the chloride) to alleviate bone…
Expand
Highly Cited
1978
Highly Cited
1978
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction
J. Welsh
Journal of Experimental Medicine
1978
Corpus ID: 9405584
Lymphocytic choriomeningitis virus (LCMV) infection of C3H/St, nude (BALB/c background), and other mice induced high levels of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE